Last verified: 17 days ago
Akkermansia Muciniphila
Also known as: AKK, Akkermansia, A. muciniphila, Akk bacteria
Evidence under review. — Not yet rated
Gut bacterium linked to metabolic health, but human evidence for direct supplementation is still early-stage.
-
What it does
Akkermansia muciniphila is a naturally occurring gut bacterium that lives in the mucus lining of the intestine. Research suggests it plays a role in maintaining gut barrier integrity and metabolic...
-
Evidence quality
Evidence base hasn't been formally rated yet. See research below.
-
Clinical dose
No established dose
What the Science Says
Akkermansia muciniphila is a naturally occurring gut bacterium that lives in the mucus lining of the intestine. Research suggests it plays a role in maintaining gut barrier integrity and metabolic health, with higher levels associated with better blood sugar control, improved HDL cholesterol, and reduced inflammation. Most human evidence comes from observational data or trials where AKK levels changed as a secondary outcome of interventions like exercise or dietary changes — not from direct AKK supplementation trials.
What It Doesn't Do
Not proven to directly treat diabetes, obesity, or cancer in humans. Lab results showing cancer cell effects don't translate to human treatment. Taking a prebiotic won't reliably raise your AKK levels — one trial showed inulin didn't increase AKK at all. No solid human evidence it improves back pain, bone density, or cognitive function on its own.
Evidence-Based Benefits
Higher AKK levels are linked to better blood sugar and cholesterol in people with type 2 diabetes.
Weak EvidenceEffective at: No established dose
Supporting studies (click to view on PubMed):
AKK is associated with a healthier gut lining and reduced metabolic inflammation.
Weak EvidenceEffective at: No established dose
Supporting studies (click to view on PubMed):
Exercise can increase AKK abundance, which may contribute to metabolic improvements.
Weak EvidenceEffective at: No established dose
Supporting studies (click to view on PubMed):
Absorption & Bioavailability
Unknown — as a live bacterium, survival through the digestive tract is uncertain. Pasteurized (postbiotic) forms are being studied as alternatives. No pharmacokinetic data provided in the reviewed studies.
Red Flags to Watch For
- Most exciting findings (cancer, bone health, disc degeneration) are from animal or cell studies — not human trials
- No standardized human dose has been established for direct AKK supplementation
- Prebiotic supplements marketed to boost AKK may not actually raise AKK levels, as shown in one clinical trial
- Only 9 registered supplement products in NIH DSLD suggests limited commercial validation and regulatory oversight
- Some studies involve engineered bacterial vesicles or lab-modified forms — not what you'd find in a standard supplement
Frequently Asked Questions
What does Akkermansia Muciniphila do?
Gut bacterium linked to metabolic health, but human evidence for direct supplementation is still early-stage.
What is the effective dose of Akkermansia Muciniphila?
No established dose
Is Akkermansia Muciniphila safe?
Most exciting findings (cancer, bone health, disc degeneration) are from animal or cell studies — not human trials
What doesn't Akkermansia Muciniphila do?
Not proven to directly treat diabetes, obesity, or cancer in humans.
Research Sources
- PubMed
- NIH DSLD
This information is for educational purposes only and is not medical advice. Always consult a healthcare professional before starting any supplement regimen. Last updated: 2026-05-25